Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 22 March

Paulina Peters
March 22, 2022

Morning Bell 21 March

Sophia Mavridis
March 21, 2022

Weekly Wrap 18 March

Sophia Mavridis
March 18, 2022

Morning Bell 17 March

Paulina Peters
March 17, 2022

Morning Bell 16 March

Sophia Mavridis
March 16, 2022

Morning Bell 15 March

Paulina Peters
March 15, 2022

Morning Bell 14 March

Sophia Mavridis
March 14, 2022

Weekly Wrap 11 March

Sophia Mavridis
March 11, 2022

Morning Bell 10 March

Sophia Mavridis
March 10, 2022

Morning Bell 9 March

Paulina Peters
March 9, 2022

Morning Bell 8 March

Sophia Mavridis
March 8, 2022

Morning Bell 7 March

Sophia Mavridis
March 7, 2022